This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,573,144 units of Ondansetron HCL 4 mg tablets. The $4,383.54 firm fixed-price contract has an ultimate completion date of December 2, 2024. This award is a delivery order placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a major pharmaceutical distributor and healthcare solutions provider that supports federal healthcare programs, particularly within the Department of Defense and Veterans Affairs systems.
Generated 2/28/25, 9:52 AM